pulmonary
投放时间: 2025-06-23 08:00:00
⚕️ Quickly Identify Low-Risk Febrile Neutropenia Patients
Use the MASCC Risk Index in ONCOassist to assess which patients can be safely managed as outpatients, helping guide decisions around hospitalization and antibiotics.
✅ Fast and intuitive scoring
✅ Supports oncology decision-making
✅ Trusted by 95,000+ professionals worldwide
📲 Download the ONCOassist app — the free go-to tool for oncologists.
搜索关键词 Febrile Neutropenia risk, Oncology decision support, Medical app, ONCOassist app, MASCC Risk Index, outpatient management, antibiotic decisions, oncology professionals, medical scoring tool, healthcare professionals优势 Fast and intuitive scoring,Supports oncology decision-making,Trusted by many professionals
展示估值
49687
热度
4784
最新发现时间
2025-06-23 08:00:00
投放天数
210
素材信息
素材类型
素材尺寸
主页ID8289873642116238611
主页名字ONCOassist
产品信息
适用范围
人民币汇率走势
CNY
关注我们

新媒网跨境发布
本站原创内容版权归作者及NMedia共同所有,未经许可,禁止以任何形式转载。